CD30L/CD30 protects against psoriasiform skin inflammation by suppressing Th17-related cytokine production by V gamma 4( ) gamma delta T cells
CD30L/CD30 protects against psoriasiform skin inflammation by suppressing Th17-related cytokine production by V gamma 4( ) gamma delta T cells
复制标题
CD30L/CD30 通过抑制 V gamma 4( ) gamma delta T 细胞产生 Th17 相关细胞因子来预防银屑病皮肤炎症
DOI:
10.1016/j.jaut.2019.04.009
复制
发表时间:
2019
影响因子:
12.8
通讯作者:
Sun Xun
中科院分区:
文献类型:
--
作者:
Yue Dan;You Yong;Zhang Xiaoqing;Wang Biao;Wang Xiao;Qi Ruiqun;Yang Fan;Meng Xin;Yoshikai Yasunobu;Wang Yuanyuan;Sun Xun
Psoriasis is a common, autoimmune, chronic inflammatory skin disease. It has been demonstrated that cutaneous T17 cells play an important pro-inflammatory role in the pathogenesis of psoriasis, through the production of various Th17-related cytokines. Our previous studies have demonstrated that CD30L/CD30 signal plays a pivotal role in the differentiation of CD4+Th17 cells and Vγ6+γδ T17 cells in the gut-associated lymphoid tissues of mouse. However, its effect on the pathogenesis of psoriasis is unknown. Here, we fully prove that CD30L/CD30 signaling plays a novel protective role in the development of psoriasis in mice, through selective inhibition of CCR6 expression and Th17-related cytokine synthesis in the Vγ4+γδ T17 cell subset. Meanwhile, treatment with agonistic anti-CD30 mAb had a significant therapeutic effect on our psoriasis mouse model. Therefore, the CD30L/CD30 signaling pathway is an ideal target for antibody therapy, which may become a new approach for the immunobiological treatment of psoriasis.